A citation-based method for searching scientific literature

Iannis Aifantis, Elizabeth Raetz, Silvia Buonamici. Nat Rev Immunol 2008
Times Cited: 302



John M Goldberg, Lewis B Silverman, Donna E Levy, Virginia Kimball Dalton, Richard D Gelber, Leslie Lehmann, Harvey J Cohen, Stephen E Sallan, Barbara L Asselin. J Clin Oncol 2003
Times Cited: 229




List of shared articles



Times cited

Analysis of the Expression of the TRBC1 in T lymphocyte tumors.
Man Chen, Aixian Wang, Shuqiang Liu, Xueying Wu, Meiwei Gong, Junyi Zhen, Minjing Fu, Hui Wang. Indian J Hematol Blood Transfus 2021
1

G1 Cell Cycle Arrest and Extrinsic Apoptotic Mechanisms Underlying the Anti-Leukemic Activity of CDK7 Inhibitor BS-181.
Shin Young Park, Ki Yun Kim, Do Youn Jun, Su-Kyeong Hwang, Young Ho Kim. Cancers (Basel) 2020
7

Targeting steroid resistance in T-cell acute lymphoblastic leukemia.
Renate De Smedt, Julie Morscio, Steven Goossens, Pieter Van Vlierberghe. Blood Rev 2019
17

T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases.
Mareike Doerrenberg, Andreas Kloetgen, Kebria Hezaveh, Wilhelm W√∂ssmann, Kirsten Bleckmann, Martin Stanulla, Martin Schrappe, Alice C McHardy, Arndt Borkhardt, Jessica I Hoell. Genes Chromosomes Cancer 2017
12

Anti-leukaemic activity of the TYK2 selective inhibitor NDI-031301 in T-cell acute lymphoblastic leukaemia.
Koshi Akahane, Zhaodong Li, Julia Etchin, Alla Berezovskaya, Evisa Gjini, Craig E Masse, Wenyan Miao, Jennifer Rocnik, Rosana Kapeller, Jeremy R Greenwood,[...]. Br J Haematol 2017
21

HSP90 inhibition leads to degradation of the TYK2 kinase and apoptotic cell death in T-cell acute lymphoblastic leukemia.
K Akahane, T Sanda, M R Mansour, T Radimerski, D J DeAngelo, D M Weinstock, A T Look. Leukemia 2016
32